Infiltrating lobular carcinoma of the female breast. Deviations from the usual histopathologic appearance
โ Scribed by Louis-Jacques Van Bogaert; Paul Maldague
- Publisher
- John Wiley and Sons
- Year
- 1980
- Tongue
- English
- Weight
- 800 KB
- Volume
- 45
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
โฆ Synopsis
Twenty-two cases of breast tumor with infiltrating lobular carcinoma were studied. Thirteen showed the classic single-file pattern as a sole component, and 6 as a predominant pattern; the less common confluent pattern was found in 3 instances as a predominant component. Mucin secretion was evidenced in 59% of the primary tumors; it was a prominent feature in only 1 case. Nine tumors were associated with in situ lobular carcinoma. In 14, nodal metastases had occurred at the moment of diagnosis. In 50% of the metastases, intracellular mucin secretion was present. It appears that the diagnosis of infiltrating lobular carcinoma relies on the convergence of multiple histocytologic hallmarks, as much in the primary tumors as in the metastases. Deviations from the classic appearance need to be recognized as true lobular carcinomas, and even in these cases it is suggested that the well established term lobular carcinoma be maintained.
๐ SIMILAR VOLUMES
FIGURE 2. Benign-appearing nodule in a patient with a history of contralateral breast carcinoma. A right craniocaudal mammogram (not shown) showed a dense breast without focal abnormality. (A) Sonography showed an ovoid, solid, well-defined, 7-mm mass (arrows). (B) Sonographic guided biopsy with a 1
Conservative treatment of infiltrating lobular carcinoma (ILC) has previously been examined only in terms of general breast carcinoma studies. However, this lesion has been shown to differ from the more common infiltrating ductal carcinoma (IDC) in estrogen receptor (ER) status, metastatic patterns,
The importance of angiogenesis, assessed by tumour microvessel density, as a marker of survival was examined in 160 patients with infiltrating lobular carcinoma of the breast (ILC). The median follow-up was 5.1 years. Of these patients, 46 were node-negative, 59 were node-positive, and in 55 the pat